A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer
Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few studies have focused on the relationships between...
Saved in:
Main Authors: | Xin Zhang, Xingda Zhang, Guozheng Li, Yi Hao, Lei Liu, Lei Zhang, Yihai Chen, Jiale Wu, Xinheng Wang, Shuai Yang, Shouping Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/3143511 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
by: Lingjuan Ruan, et al.
Published: (2018-01-01) -
Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA
by: Jun-Yu Zhu, et al.
Published: (2022-01-01) -
lncRNA-Triggered Macrophage Inflammaging Deteriorates Age-Related Diseases
by: Lulingxiao Nie, et al.
Published: (2019-01-01) -
Analysis of the lncRNA-Associated Competing Endogenous RNA (ceRNA) Network for Tendinopathy
by: Bing-Zhe Huang, et al.
Published: (2022-01-01) -
Identification of a Seven-lncRNA-mRNA Signature for Recurrence and Prognostic Prediction in Relapsed Acute Lymphoblastic Leukemia Based on WGCNA and LASSO Analyses
by: Haiyan Qi, et al.
Published: (2021-01-01)